Shravanthi Reddy

Dr. Reddy serves as ClearSight’s Chief Executive Officer. She is responsible for strategic planning for the company’s efforts to move forward with product R&D, regulatory strategy, and path to market. As VP of R&D for parent company Sharklet Technologies, Inc., she is instrumental in securing licensing deals with strategic partners for use of the Sharklet micropattern on medical devices. She leads joint development efforts with partners including Cook Medical in bringing these novel devices to market, providing expertise on the Sharklet technology from both a technical standpoint as well as engineering, regulatory, and clinical phases of product development.

Dr. Reddy holds a PhD in Chemical Engineering from the University of Texas at Austin, where her research focused on microfluidics in the Step and Flash Nano-Imprint Lithography process. She earned a BSE degree in Chemical Engineering from Princeton University. She received a Humboldt Fellowship for postdoctoral research at the Max Planck Institute in Stuttgart, Germany. Her work has been published in numerous scientific journals including Clinical and Translational Medicine, Journal of Endourology, Advanced Materials, Microelectronic Engineering, Physics of Fluids.